참고문헌
- Aguiar, A.J., Krc, J., Kinkel, A.W., Samyn, J.C., 1967. Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate. J. Pharm. Sci. 56, 847-853. https://doi.org/10.1002/jps.2600560712
- Aguiar, A.J., Zelmer, J.E, 1969. Dissolution behavior of polymorphs of chloramphenicol palmitate and mefanamic acid. J. Pharm. Sci. 58, 983-987. https://doi.org/10.1002/jps.2600580817
- Beyer, T., Day, G.M., Price, S.L., 2001. The prediction, morphology and mechanical properties of the polymorphs of paracetamol. J. Am. Chem. Soc. 123, 5086-5094. https://doi.org/10.1021/ja0102787
- Byrn, S., Pfeiffer, R., Ganey, M., Hoiberg, C., Poochikian, G., 1995. Pharmaceutical solids: A strategic approach to regulatory considerations. Pharm. Res. 12, 945-954. https://doi.org/10.1023/A:1016241927429
- Byrn, S.R., Pfeiffer, R.R., Stowell, J.G., 1999. Solid-state chemistry of drugs (2nd ed.). SSCI, Inc., West Lafayette, Indiana.
- Bauer, J., Spanton, S., Henry, R., Quick, J., Dziki, W., Porter, W., Morris, J., 2001. Ritonavir: an extraordinary example of conformational polymorphism. Pharm. Res. 18, 859-866. https://doi.org/10.1023/A:1011052932607
- Center for Drug Evaluation and Research Guidance: Submitting Supporting Documentation in Drug Applications for the Manufacture of Drug Substances, February 1987.
- Chen, X., Morris, K.R., Griesser, U.J., Byrn S.R., Stowell, J.G., 2002. Reactivity differences of indomethacin solid forms with ammonia gas. J. Am. Chem. Soc. 124, 15012-15019. https://doi.org/10.1021/ja017662o
- Di Martino, P., Guyot-Hermann, A.M., Conflant, P., Drache, M., Guyot, J.C., 1996. A new pure paracetamol for direct compression: the orthorhombic form. Int. J. Pharm. 128, 1-8. https://doi.org/10.1016/0378-5173(95)04127-3
- Giron, D., Grant, D.J.W., 2002. Evaluation of solid-state properties of salts. In Stahl, P.H., Wermuth, C.G. (eds.) Handbook of pharmaceutical salts: properties, selection, and use. Wiley-VCH, Surich, Switzerland, pp 41-81.
- Giron, D., 2001. Investigation of polymorphism and pseudo-polymorphism in pharmaceuticals by combined thermoanalytical techniques. J. Therm. Anal. Calorim., 64, 37-60. https://doi.org/10.1023/A:1011572610005
- Grant, D.J.W., 1999. Theory and origin of polymorphism. In H. G. Brittain (ed.) Polymorphism in Pharmaceutical Solids. Marcel Dekker, Inc., New York, pp. 1-34.
- International Conference on Harmonization Q6A Guideline: Specifications for New Drug Substances and Products: Chemical Substances, October 1999.
- Joiris, E., Di Martino, P., Berneron, C., Guyot-Hermann, A.M., Guyot, J.C., 1998. Compression behavior of orthorhombic paracetamol. Pharm. Res. 15, 1122-1130. https://doi.org/10.1023/A:1011954800246
- Ku, M.S., 2008. Use of the Biopharmaceutical Classification System in Early Drug Development. AAPS J. 10, 208-212. https://doi.org/10.1208/s12248-008-9020-0
- Liebenberg, W., de Villiers, M., Wurster, D.E., Swanepoel, E., Dekker, T.G., Lotter, A.P., 1999. The effect of polymorphism on powder compaction and dissolution properties of chemically equivalent oxytetracycline hydrochloride powders. Drug Dev. Ind. Pharm. 25, 1027-1033. https://doi.org/10.1081/DDC-100102265
- Lohani, S., Grant, D.J.W., 2006. Thermodynamics of polymorph. In Hilfiker, R. (ed.) Polymorphism in the pharmaceutical industry. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, pp 21-42.
- Meyer, M.C., Straughn, A.B., Jarvi, E.J., Wood, G.C., Pelsor, F.R., Shah, V.P., 1992. The bioinequivalence of carbamazepine tablets with a history of clinical failures. Pharm. Res. 9, 1612-1616. https://doi.org/10.1023/A:1015872626887
- Nichols, G., Frampton, C.S., 1998. Physicochemical characterization of the orthorhombic polymorph of paracetamol crystallized from solution. J. Pharm. Sci. 87, 684-693. https://doi.org/10.1021/js970483d
- Otsuka, M., Hasegawa, H., Matsuda, Y., 1999. Effect of polymorphic forms of bulk powders on pharmaceutical properties of carbamazepine granules. Chem. Pharm. Bull. 47, 852-856. https://doi.org/10.1248/cpb.47.852
- Roberts, R.J., Payne, R.S., Rowe, R.C., 2000. Mechanical property predictions for polymorphs of sulphathiazole and carbamazepine. Eur. J. Pharm. Sci. 9, 277-283. https://doi.org/10.1016/S0928-0987(99)00065-2
- Singhhal, D., Curatolo, W., 2004. Drug polymorphism and dosage form design: a practical perspective. Adv. Drug Del. Rev. 56, 335-347. https://doi.org/10.1016/j.addr.2003.10.008
- Summers, M.P., Enever, R.P., Carless, J.E., 1976. The influence of crystal form on the radial stress transition characteristics of pharmaceutical materials. J. Pharm. Pharmacol. 28, 89-99. https://doi.org/10.1111/j.2042-7158.1976.tb04105.x
- Sun, C., Grant, D.J.W., 2001. Influence of crystal structure on the tableting properties of sulfamerazine polymorphs. Pharm. Res. 18, 274-280. https://doi.org/10.1023/A:1011038526805
- Young, W.W.L., Suryanarayanan, R., 1991. Kinetics of transition of anhydrous carbamazepine to carbamazepine dihydrate in aqueous suspensions. J. Pharm. Sci. 80, 496-500. https://doi.org/10.1002/jps.2600800519